FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tatiana Voronina

Research Profile

Living Beings

Rats
Mouse

Chemicals & Drugs

Physiology

Activities & Behaviors

Concepts & Ideas

Co-author Network

Publications

TOP 3
Rita U Ostrovskaya; I V Ozerova; T A Gudascheva; E A Ivanova; IG Kapitsa; Tatiana A Voronina; SB Seredenin
Efficiency of noopept in streptozotocin-induced diabetes in rats.
S V Stovbun; Tatiana A Voronina; A M Zanin; T S Kalinina; A V Kiselev; A I Mikhailov; A A Berlin
Effects of physicochemical forms of phenazepam and Panavir on their action at ultra-low doses.
Yu B Filatova; P M Klodt; Vladimir S Kudrin; LN Nerobkova; F K Rider; Tatiana A Voronina; G N Avakyan
Changes in the levels of inhibitory and excitatory amino acids in the brain structures of female rats with cobalt epileptogenic focus during different phases of the estrous cycle.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tatiana Voronina (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rita U Ostrovskaya; I V Ozerova; T A Gudascheva; E A Ivanova; IG Kapitsa; Tatiana A Voronina; SB Seredenin
Efficiency of noopept in streptozotocin-induced diabetes in rats.
Bulletin of experimental biology and medicine 2013;154(3):334-8.
2012: S V Stovbun; Tatiana A Voronina; A M Zanin; T S Kalinina; A V Kiselev; A I Mikhailov; A A Berlin
Effects of physicochemical forms of phenazepam and Panavir on their action at ultra-low doses.
Bulletin of experimental biology and medicine 2012;153(4):455-8.
2011: Yu B Filatova; P M Klodt; Vladimir S Kudrin; LN Nerobkova; F K Rider; Tatiana A Voronina; G N Avakyan
Changes in the levels of inhibitory and excitatory amino acids in the brain structures of female rats with cobalt epileptogenic focus during different phases of the estrous cycle.
Bulletin of experimental biology and medicine 2011;152(1):47-9.
2009: Tatiana A Voronina; M V Belopol'skaya; I A Kheyfets; Yu L Dugina; SA Sergeeva; O I Epshtein
Effect of ultralow doses of antibodies to S-100 protein in animals with impaired cognitive function and disturbed emotional and neurological status under conditions of experimental Alzheimer disease.
Bulletin of experimental biology and medicine 2009;148(3):533-5.
2009: Tatiana A Voronina; I A Kheyfets; Yu L Dugina; SA Sergeeva; O I Epshtein
Study of the effects of preparation containing ultralow doses of antibodies to S-100 protein in experimental hemorrhagic stroke.
Bulletin of experimental biology and medicine 2009;148(3):530-2.
2009: Tatiana A Voronina; I A Kheyfets; Guenadiy Molodavkin; Yu L Dugina; M V Borodavkina; SA Sergeeva; O I Epshtein
Antiaggressive activity of antibodies to S-100 protein in ultralow doses.
Bulletin of experimental biology and medicine 2009;148(3):527-9.
2009: Tatiana A Voronina; Guenadiy Molodavkin; M V Borodavkina; I A Kheyfets; Yu L Dugina; SA Sergeeva
Nootropic and antiamnestic effects of tenoten (pediatric formulation) in immature rat pups.
Bulletin of experimental biology and medicine 2009;148(3):524-6.
2009: G N Aleeva; Guenadiy Molodavkin; Tatiana A Voronina
Comparison of antidepressant effects of azafan, tianeptine, and paroxetine.
Bulletin of experimental biology and medicine 2009;148(1):54-6.
2008: I G Kapitza; T S Kalinina; LN Nerobkova; Tatiana A Voronina; P M Klodt; Victor Narkevich; Vladimir S Kudrin
Relationship between the severity of hypokinesia induced by neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and neurochemical changes in brain structures of C57Bl/6 mice.
Bulletin of experimental biology and medicine 2008;146(1):52-5.
2008: K B Kurakhmaeva; Tatiana A Voronina; I G Kapica; J Kreuter; L N Nerobkova; SB Seredenin; V Yu Balabanian; R N Alyautdin
Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80.
Bulletin of experimental biology and medicine 2008;145(2):259-62.
2007: P S Gromovykh; LS Guzevatykh; KV Shevchenko; Lyudmila A Andreeva; LIu Alfeeva; Valery P Shevchenko; IIu Nagaev; Tatiana A Voronina; NF Miasoedov
[Synthesis, pharmacokinetics, and metabolism of the C-terminal tripeptide of dermorphin and its diastereomer].
Bioorganicheskaia khimiia 2007;33(6):581-7.
2007: OI Epstein; Tatiana A Voronina; G M Molodavkin; M V Belopol'skaya; I A Kheyfets; J L Dugina; SA Sergeeva
Study of bipathic effect of phenazepam.
Bulletin of experimental biology and medicine 2007;144(4):536-8.
2007: LS Guzevatykh; Tatiana A Voronina; TG Emel'ianova; Lyudmila A Andreeva; P S Gromovykh; NF Miasoedov; SB Seredenin
[Comparative analysis of analgesic activities of dermorphin, [DPro6]-dermorphin, and their C-terminal tripeptides].
Izvestiia Akademii nauk. Seriia biologicheskaia / Rossiĭskaia akademiia nauk 2007;(5):577-82.
2007: I A Kheifets; Yu L Dugina; Tatiana A Voronina; Guenadiy Molodavkin; Andrey Martyushev-Poklad; SA Sergeeva; OI Epstein
Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to S-100 protein.
Bulletin of experimental biology and medicine 2007;143(5):598-600.
2007: Guenadiy Molodavkin; Tatiana A Voronina; LI Larentsova; M I Pchelkina; OK Meletova
[Combined action of mexidol and non-narcotic analgesics on pain thresholds and emotional stress behavior in animals].
Eksperimental'naia i klinicheskaia farmakologiia 2007;70(2):16-9.
2007: Guenadiy Molodavkin; Tatiana A Voronina; OK Meletova
[Comparative study of the effects of amitriptyline, fluoxetine, and tianeptine on the amplitude of transcallosal evoked potentials].
Eksperimental'naia i klinicheskaia farmakologiia 2007;70(1):3-5.
2006: Tatiana A Voronina; GM Moldavkin; I I Babaev; LD Smirnov; VV Iasnetsov; VS Shashkov
[Antistressor and analgesic effects of mexidol, diazepam, paracetamol, and their combinations].
Eksperimental'naia i klinicheskaia farmakologiia 2006;69(4):6-9.
2006: GM Moldavkin; Tatiana A Voronina; GG Neznamov; O K Maletova; N V Eliava
[Participation of GABA--benzodiazepine receptor complex in the anxiolytic effect of piracetam].
Eksperimental'naia i klinicheskaia farmakologiia 2006;69(3):7-9.
2006: EA Katunina; E A Malykhina; N V Kuznetsov; GN Avakian; E i Gusev; LN Nerobkova; Tatiana A Voronina; IV Barskov
[Antioxidants in complex treatment of Parkinson's disease].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoĭ promyshlennosti Rossiĭskoĭ Federatsii, Vserossiĭskoe obshchestvo nevrologov [i] Vserossiĭskoe obshchestvo psikhiatrov 2006;106(9):22-8.
2005: Irina Galaeva; Taissia L Garibova; Tatiana A Voronina; SB Seredenin
Neuroprotective effects of afobazol in experimental cerebral hemorrhage.
Bulletin of experimental biology and medicine 2005;140(5):535-7.
2005: GM Moldavkin; Tatiana A Voronina
[Computer software for data acquisition during behavioral tests].
Eksperimental'naia i klinicheskaia farmakologiia 2005;68(6):55-8.
2005: Basel Abdel wahab; VE Petrov; SS Trofimov; Tatiana A Voronina; RN Aliautdin
[Antiamnesic activity of nerve growth factor adsorbed on poly(butyl) cyanoacrylate nanoparticles coated with polysorbate-80].
Eksperimental'naia i klinicheskaia farmakologiia 2005;68(6):3-8.
2005: T S Kalinina; LN Nerobkova; Tatiana A Voronina; S V Stovbun; AA Litvin; V I Sergienko
Study of antiparkinsonic activity of panavir on a model of Parkinson syndrome induced by systemic administration of MPTP to outbred rats and C57Bl/6 mice.
Bulletin of experimental biology and medicine 2005;140(1):55-7.
2005: SS Trofimov; Tatiana A Voronina; LS Guzevatykh
Early postnatal effects of noopept and piracetam on declarative and procedural memory of adult male and female rats.
Bulletin of experimental biology and medicine 2005;139(6):683-7.
2005: LS Guzevatykh; D V Valuĭskikh; Tatiana A Voronina; TG Emel'ianova; Lyudmila A Andreeva; LIu Alfeeva; NF Miasoedov
[Comparative study of the physical dependence on proline analog of dermorphin and morphine].
Eksperimental'naia i klinicheskaia farmakologiia 2005;68(3):16-9.
2005: Guenadiy Molodavkin; Tatiana A Voronina; OK Meletova
[Comparative study of the antidepressant and anxiolytic activity of fluoxetine and tianeptine].
Eksperimental'naia i klinicheskaia farmakologiia 2005;68(3):10-2.
2005: GA Romanova; Tatiana A Voronina; Yu L Dugina; Andrey Martyushev-Poklad; SA Sergeeva; OI Epstein; IV Barskov
Neuroprotective activity of proproten in rats with experimental local photothrombosis of the prefrontal cortex.
Bulletin of experimental biology and medicine 2005;139(4):404-7.
2005: SB Seredenin; OIu Kravtsova; A K Sarieva; VP Zherdev; G B Kolyvanova; Tatiana A Voronina
[Biotransformation of mexidol in inbred BALB/C and C57BL/6 mice].
Eksperimental'naia i klinicheskaia farmakologiia 2005;68(2):40-3.
2005: LS Guzevatykh; D V Valuĭskiĭ; Tatiana A Voronina; TG Emel'ianova; Lyudmila A Andreeva; LIu Alfeeva; SB Seredenin; NF Miasoedov
[Analgesic activity of dermorphin and its proline analogs].
Eksperimental'naia i klinicheskaia farmakologiia 2005;68(2):8-10.
2005: Tatiana A Voronina; LS Guzevatykh; SS Trofimov
[Comparative study of the long-term behavioral effects of noopept and piracetam in adult male rats and female rats in postnatal period].
Eksperimental'naia i klinicheskaia farmakologiia 2005;68(2):3-7.
2005: R K Arakelian; LN Nerobkova; EA Katunina; EA Val'dman; IG Kapitsa; Tatiana A Voronina; GN Avakian; E i Gusev
[Functional brain activity in patients with Parkinson's disease during amantadin-sulfate therapy].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoĭ promyshlennosti Rossiĭskoĭ Federatsii, Vserossiĭskoe obshchestvo nevrologov [i] Vserossiĭskoe obshchestvo psikhiatrov 2005;105(4):17-21.
2005: RU Ostrovskaia; M V Retiunskaia; LS Guzevatykh; Tatyana A Gudasheva; Tatiana A Voronina; S B Seredin
[Dilept: a tripeptoid neurotensin analog combining neuroleptic activity with positive mnemotropic action].
Eksperimental'naia i klinicheskaia farmakologiia 2005;68(1):3-6.
2004: Athina Geronikaki; Eugene Babaev; John C Dearden; Wim Dehaen; Dmitrii A Filimonov; Irina Galaeva; Valentina Krajneva; Alexey A Lagunin; Fliur Macaev; Guenadiy Molodavkin; Vladimir Poroikov; Serghei Pogrebnoi; Victor Saloutin; Alla Stepanchikova; Eugenia Stingaci; Natalia Tkach; Liudmila Vlad; Tatiana A Voronina
Design, synthesis, computational and biological evaluation of new anxiolytics.
Bioorganic & medicinal chemistry 2004;12(24):6559-68.
2004: Guenadiy Molodavkin; M K Cadikov; Tatiana A Voronina; Z U Sadikova; OK Meletova; M I Pchelkina; LI Larentsova; TS Gan'shina; RS Mirzoian
[Effect of typical and atypical anxiolytics on the behavior and electrophysiological parameters of rats with model cerebrovascular pathology].
Eksperimental'naia i klinicheskaia farmakologiia 2004;67(6):16-9.
2004: OIu Kravtsova; Tatiana A Voronina; AK Sariev
[Investigation of the effects of mexidol in escapable and inescapable emotional stress in inbred BALB/C and C57BL/6 mice].
Eksperimental'naia i klinicheskaia farmakologiia 2004;67(6):8-11.
2004: Guenadiy Molodavkin; Tatiana A Voronina; Zh Aldarmaa; OK Meletova
[Stress-induced alteration of the antiaggressive effect of anxiolytics].
Eksperimental'naia i klinicheskaia farmakologiia 2004;67(4):3-6.
2004: Athina Geronikaki; John C Dearden; Dmitrii A Filimonov; Irina Galaeva; Taissia L Garibova; Tatyana A Gloriozova; Valentina Krajneva; Alexey A Lagunin; Fliur Macaev; Guenadiy Molodavkin; Vladimir Poroikov; Serghei Pogrebnoi; Felix Shepeli; Tatiana A Voronina; Maria Tsitlakidou; Liudmila Vlad
Design of new cognition enhancers: from computer prediction to synthesis and biological evaluation.
Journal of medicinal chemistry 2004;47(11):2870-6.
2004: EA Katunina; E V Samoĭlova; EA Val'dman; LN Nerobkova; Tatiana A Voronina; GN Avakian
[Comparative study of neurophysiological effects of adamantane derivatives in the experimental parkinsonism model].
Eksperimental'naia i klinicheskaia farmakologiia 2004;67(2):16-8.
2004: GN Avakian; Tatiana A Voronina; EA Val'dman; LN Nerobkova; EA Katunina; E V Samoĭlova
[Clinico-neurophysiologic and experimental study of the peculiarities of adamantan-sulphate treatment in Parkinson's disease].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoĭ promyshlennosti Rossiĭskoĭ Federatsii, Vserossiĭskoe obshchestvo nevrologov [i] Vserossiĭskoe obshchestvo psikhiatrov 2004;104(9):18-22.
2004: S S Boĭko; S A Korotkov; VP Zherdev; Tatyana A Gudasheva; RU Ostrovskaia; Tatiana A Voronina
[Interspecies differences of noopept pharmacokinetics].
Eksperimental'naia i klinicheskaia farmakologiia 2004;67(1):40-3.
2004: EA Val'dman; LN Nerobkova; Tatiana A Voronina
[Estimation of the protective effect of the novel potential antiparkinsonian agent himantane against MPTP neurotoxicity].
Eksperimental'naia i klinicheskaia farmakologiia 2004;67(1):7-10.
2004: OV Povarova; Taissia L Garibova; EI Kalenikova; Irina Galaeva; V A Kraĭneva; OS Medvedev; Tatiana A Voronina
[Effect of phenyl-tert-butylnitrone, mexidol and nooglutil on the ischemic lesion zone and memory in rats following middle cerebral artery occlusion].
Eksperimental'naia i klinicheskaia farmakologiia 2004;67(1):3-6.
2003: M V Retyunskaya; LS Guzevatykh; NA Bondarenko; Tatyana A Gudasheva; Rita U Ostrovskaya; Tatiana A Voronina
Neuromodulatory mechanism underlying the effect of the atypical dipeptide neuroleptic dilept.
Bulletin of experimental biology and medicine 2003;136(5):467-70.
2003: EA Val'dman; Tatiana A Voronina; L N Aksenova; OA Buneeva; Alexei E Medvedev
[Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
Eksperimental'naia i klinicheskaia farmakologiia 2003;66(5):3-5.
2003: Taissia L Garibova; Irina Galaeva; Tatiana A Voronina; V A Kraĭneva; IG Kapitsa; S V Kirichenko; AN Makarenko; G R Mirzoian; E A Kuznetsova
[Effect of nooglutil on rats with intracerebral posttraumatic hematoma (hemorrhagic stroke)].
Eksperimental'naia i klinicheskaia farmakologiia 2003;66(3):13-6.
2003: Tatiana A Voronina; O I Epshteĭn; Guenadiy Molodavkin; S A Sergeeva; V A Kraĭneva
[Spectrum of psychotropic effects and mechanism of action of ultra low doses of the antibodies to S-100 protein (proproten)].
Radiatsionnaia biologiia, radioecologiia / Rossiĭskaia akademiia nauk 2003;43(3):291-3.
2003: Guenadiy Molodavkin; Tatiana A Voronina; L I Cherniavskaia; E B Burlakova
[Effects of psychotropic drugs of different classes injected in super small doses].
Radiatsionnaia biologiia, radioecologiia / Rossiĭskaia akademiia nauk 2003;43(3):287-90.
2003: OI Epstein; Guenadiy Molodavkin; Tatiana A Voronina; SA Sergeeva
Antidepressant properties of Proproten and amitriptyline: comparative experimental study.
Bulletin of experimental biology and medicine 2003;135 Suppl 7():123-4.
2003: Guenadiy Molodavkin; Tatiana A Voronina; L I Chernyavskaya; E B Burlakova; N I Khorseva; SB Seredenin
Pharmacological activity of phenazepam and flunitrazepam in ultralow doses.
Bulletin of experimental biology and medicine 2003;135 Suppl 7():39-41.
2003: Tatiana A Voronina; Guenadiy Molodavkin; L I Chernyavskaya; SB Seredenin; E B Burlakova
Effects of phenazepam in ultralow doses on bioelectric activity of the brain and behavior of rats in various models of anxiety.
Bulletin of experimental biology and medicine 2003;135 Suppl 7():14-6.
2003: VP Zherdev; Tatiana A Voronina; Taissia L Garibova; GB Kolyvanov; AA Litvin; AK Sariev; V N Tokhmakhchi; A E Vasil'ev
[Pharmacokinetics and efficacy of phenazepam after transdermal and enteral administration in rats].
Eksperimental'naia i klinicheskaia farmakologiia 2003;66(1):50-3.
2002: Tatiana A Voronina; Gilyana Borlikova; Taissia L Garibova; T V Proskuryakova; O B Petrichenko; SG Burd; G N Avakyan
Effect of nooglutil on benzodiazepine withdrawal syndrome and binding of 3H-spiperone with D2 receptors in rat striatum.
Bulletin of experimental biology and medicine 2002;134(5):448-50.
2002: RU Ostrovskaia; Tatyana A Gudasheva; Tatiana A Voronina; SB Seredenin
[The original novel nootropic and neuroprotective agent noopept].
Eksperimental'naia i klinicheskaia farmakologiia 2002;65(5):66-72.
2002: Tatiana A Voronina; SB Seredenin
[Prospects of the search for novel anxiolytics].
Eksperimental'naia i klinicheskaia farmakologiia 2002;65(5):4-17.
2002: Guenadiy Molodavkin; Tatiana A Voronina; E Ia Ramkhin; Zh Aldarmaa
[Stress-induced alteration of the anticonflict effect of anxiolytics].
Eksperimental'naia i klinicheskaia farmakologiia 2002;65(4):3-6.
2002: LS Guzevatykh; TG Emel'ianova; AB Usenko; Lyudmila A Andreeva; LIu Alfeeva; Tatiana A Voronina; NF Miasoedov
[Effect of structural changes of Pro6 in dermorphin molecule on its antinociceptive activity].
Izvestiia Akademii nauk. Seriia biologicheskaia / Rossiĭskaia akademiia nauk 2002;(4):472-6.
2002: OL Badalian; LN Nerobkova; Tatiana A Voronina; GN Avakian; N V Markina; SG Burd; M I Stoĭko; O M Oleĭnikova; A A Mitrofanov
[Effect of carbamazepine on the structure-function relations in the development of the epileptic structure].
Eksperimental'naia i klinicheskaia farmakologiia 2002;65(2):6-8.
2002: Guenadiy Molodavkin; Gilyana Borlikova; Tatiana A Voronina; Tatyana A Gudasheva; RU Ostrovskaia; NA Tushmalova; SB Seredenin
[Effect of the novel dipeptide nootropic agent noopept and its metabolite cyclo-L-prolylglycine on the transcallosal evoked potential in the rat brain].
Eksperimental'naia i klinicheskaia farmakologiia 2002;65(2):3-5.
2002: GG Neznamov; V V Koshelev; Tatiana A Voronina; SS Trofimov
[Experimental and clinical rationale for complex treatment of mental disorders in clean-up workers of the Chernobyl nuclear plant accident].
Eksperimental'naia i klinicheskaia farmakologiia 2002;65(2):12-6.
2002: LI Larentsova; Iu M Maksimovskiĭ; Tatiana A Voronina; K R Grigorian
[Antioxidant Mexidol premedication of patients with periodontitis during antihomotoxic therapy].
Stomatologii͡a 2002;81(2):20-2.
2002: LS Guzevatykh; RU Ostrovskaia; Tatyana A Gudasheva; N I Zaĭtseva; Tatiana A Voronina
[Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
Eksperimental'naia i klinicheskaia farmakologiia 2002;65(1):3-6.
2002: Tatiana A Voronina; M I Stoĭko; LN Nerobkova; GN Avakian; V A Kraĭneva
[Effect of phenytoin on neurotoxin homocysteine thiolactone-induced convulsions and epileptic status in rats with cobalt-induced epilepsy].
Eksperimental'naia i klinicheskaia farmakologiia 2002;65(1):15-8.
2001: EA Andiarzhanova; EA Val'dman; Vladimir S Kudrin; K S Raevskiĭ; Tatiana A Voronina
[Effect of the new potential anti-Parkinson agent, hymantane, on levels of monoamines and their metabolites in rat striatum (a microdialysis study)].
Eksperimental'naia i klinicheskaia farmakologiia 2001;64(6):13-6.
2001: Rita U Ostrovskaya; T K Mirsoev; GA Romanova; Tatyana A Gudasheva; E V Kravchenko; C C Trofimov; Tatiana A Voronina; SB Seredenin
Proline-containing dipeptide GVS-111 retains nootropic activity after oral administration.
Bulletin of experimental biology and medicine 2001;132(4):959-62.
2001: SS Trofimov; RU Ostrovskaia; Tatiana A Voronina
[The effect of training conditions on passive avoidance performance in rats].
Zhurnal vyssheĭ nervnoĭ deiatelnosti imeni I P Pavlova 2001;51(2):256-61.
2001: GI Nezhinskaia; EA Val'dman; PG Nazarov; Tatiana A Voronina
[Immunotropic activity of a potential antiparkinson agent himantane].
Eksperimental'naia i klinicheskaia farmakologiia 2001;64(2):60-3.
2000: Guenadiy Molodavkin; Tatiana A Voronina; J Aldarmaa
[Psychotropic effect of the Astragalus mongolicus preparation].
Eksperimental'naia i klinicheskaia farmakologiia 2000;63(6):12-4.
2000: LN Nerobkova; EA Val'dman; Tatiana A Voronina; N V Markina; L M Sharkova
[Effect of the novel aminoadamantane derivative A-7 on Parkinsonian syndrome induced by systemic administration of neurotoxin MPTP].
Eksperimental'naia i klinicheskaia farmakologiia 2000;63(3):3-6.
2000: SS Boiko; Rita U Ostrovskaya; VP Zherdev; S A Korotkov; Tatyana A Gudasheva; Tatiana A Voronina; SB Seredenin
Pharmacokinetics of new nootropic acylprolyldipeptide and its penetration across the blood-brain barrier after oral administration.
Bulletin of experimental biology and medicine 2000;129(4):359-61.
2000: Tatiana A Voronina; Guenadiy Molodavkin; Gilyana Borlikova; RU Ostrovskaia; NA Tushmalova; G G Naznamov
[The nootropic and anxiolytic properties of different doses of piracetam].
Eksperimental'naia i klinicheskaia farmakologiia 2000;63(2):9-11.
2000: SS Trofimov; Gilyana Borlikova; E V Kravchenko; A N Inozemtsov; RU Ostrovskaia; Tatiana A Voronina
[Is "scopolamine-induced amnesia" in rats the result of state-dependent learning?].
Zhurnal vyssheĭ nervnoĭ deiatelnosti imeni I P Pavlova 2000;50(2):252-60.
1999: Taissia L Garibova; Tatiana A Voronina; V A Kraĭneva; EA Val'dman
[The anxiolytic effect of ondansetron and its capacity to eliminate the benzodiazepine abstinence syndrome in rats].
Eksperimental'naia i klinicheskaia farmakologiia 1999;62(6):16-9.
1999: Tatyana A Gudasheva; RU Ostrovskaia; SS Trofimov; Tatiana A Voronina; AP Skoldinov; SB Seredenin
[Novel endogenous dipeptide cycloprolyl-glycine is similar to pyracetam in selectivity of their mnemotropic effect].
Biulleten' eksperimental'noĭ biologii i meditsiny 1999;128(10):411-3.
1999: T S Kalinina; Taissia L Garibova; Tatiana A Voronina
Discriminative effects of phenazepam and gidazepam in rats: comparison with other GABA-related drugs.
Pharmacology, biochemistry, and behavior 1999;64(2):397-401.
1999: L S Asmakova; T S Kalinina; Rita U Ostrovskaya; Tatyana A Gudasheva; NI Zaitseva; NA Bondarenko; Tatiana A Voronina; S B Seredenin
Comparison of antipsychotic activity and discriminative stimulus effects of the novel acylprolyltyrosine containing compound, GZR-123, and sulpiride.
Pharmacology, biochemistry, and behavior 1999;64(2):359-62.
1999: Rita U Ostrovskaya; GA Romanova; IV Barskov; E V Shanina; Tatyana A Gudasheva; I V Victorov; Tatiana A Voronina; SB Seredenin
Memory restoring and neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model.
Behavioural pharmacology 1999;10(5):549-53.
1999: EA Val'dman; Tatiana A Voronina; LN Nerobkova
[The antiparkinson activity of a new adamantane derivative].
Eksperimental'naia i klinicheskaia farmakologiia 1999;62(4):3-6.
1998: Tatiana A Voronina; S B Seredenin
[Nootropic preparations, the achievements and new problems].
Eksperimental'naia i klinicheskaia farmakologiia 1998;61(4):3-9.
1998: AN Inozemtsev; SS Trofimov; Gilyana Borlikova; F A Firova; LL Pragina; Tatyana A Gudasheva; RU Ostrovskaia; NA Tushmalova; Tatiana A Voronina
[The effect of the new nootropic dipeptide GVS-111 in different functional disorders of the escape reaction].
Eksperimental'naia i klinicheskaia farmakologiia 1998;61(3):10-2.
1998: Taissia L Garibova; EA Val'dman; Tatiana A Voronina; V A Kraĭneva
[Effect of calcium channel blocker nifedipine on anxiety and seizure manifestations of abstinence syndrome in rats after withdrawal of long-term diazepam administration].
Biulleten' eksperimental'noĭ biologii i meditsiny 1998;125(5):538-40.
1998: Guenadiy Molodavkin; Zh Aldarmaa; Tatiana A Voronina; B Davgatsérén
[Behavioral and electrophysiologic analysis of the anxiolytic effect of astragalus mongolian].
Biulleten' eksperimental'noĭ biologii i meditsiny 1998;125(4):407-9.
1998: Tatyana A Gudasheva; Tatiana A Voronina; Rita U Ostrovskaya; NI Zaitseva; NA Bondarenko; V K Briling; L S Asmakova; GG Rozantsev; SB Seredenin
Design of N-acylprolyltyrosine "tripeptoid" analogues of neurotensin as potential atypical antipsychotic agents.
Journal of medicinal chemistry 1998;41(3):284-90.
1998: AN Inozemtsev; S B Bokieva; A B Spineĭ; Tatiana A Voronina; NA Tushmalova
[Comparison of effects of haloperidol and phenamine on acquisition and functional disturbance of escape reaction].
Biulleten' eksperimental'noĭ biologii i meditsiny 1998;125(1):56-8.
1997: AV Lysenko; NI Uskova; RU Ostrovskaia; Tatyana A Gudasheva; Tatiana A Voronina
[Dipeptide nootropic agent GVS-111 prevents accumulation of the lipid peroxidation products during immobilization].
Eksperimental'naia i klinicheskaia farmakologiia 1997;60(5):15-8.
1997: Guenadiy Molodavkin; Tatiana A Voronina; RU Ostrovskaia
[Electrophysiological and neuropharmacological analyses of interaction of the excitation and inhibition systems in the cerebral cortex of rats].
Biulleten' eksperimental'noĭ biologii i meditsiny 1997;124(9):315-8.
1997: Tatiana A Voronina; Guenadiy Molodavkin; L I Cherniavskaia; SB Seredenin; E B Burlakova
[Effect of extremely low doses of phenazepam on EEG of rats and their behavior in various models of anxiety].
Biulleten' eksperimental'noĭ biologii i meditsiny 1997;124(9):308-10.
1997: Tatyana A Gudasheva; S S Boyko; Rita U Ostrovskaya; Tatiana A Voronina; V K Akparov; SS Trofimov; GG Rozantsev; AP Skoldinov; VP Zherdev; SB Seredenin
The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine.
European journal of drug metabolism and pharmacokinetics 1997;22(3):245-52.
1997: Elena I Solntseva; Julia V Bukanova; Rita U Ostrovskaya; Tatyana A Gudasheva; Tatiana A Voronina; Vladimir G Skrebitsky
The effects of piracetam and its novel peptide analogue GVS-111 on neuronal voltage-gated calcium and potassium channels.
General pharmacology 1997;29(1):85-9.
1997: Rita U Ostrovskaya; GA Romanova; SS Trofimov; Tatyana A Gudasheva; Tatiana A Voronina; J A Halikas; SB Seredenin
The novel substituted acylproline-containing dipeptide, GVS-111, promotes the restoration of learning and memory impaired by bilateral frontal lobectomy in rats.
Behavioural pharmacology 1997;8(2-3):261-8.
1997: S S Boĭko; VP Zherdev; A A Dvorianinov; Tatyana A Gudasheva; RU Ostrovskaia; Tatiana A Voronina; GG Rozantsev; SB Seredenin
[The pharmacokinetics of the dipeptide analog of piracetam with nootropic activity GVS-111 and of its basic metabolites].
Eksperimental'naia i klinicheskaia farmakologiia 1997;60(2):53-5.
1997: Guenadiy Molodavkin; Tatiana A Voronina
[Buspirone--a wide-spectrum preparation].
Eksperimental'naia i klinicheskaia farmakologiia 1997;60(2):3-6.
1997: SS Trofimov; RU Ostrovskaia; Tatiana A Voronina
[Postnatal stress enhances impairment of bilateral avoidance learning in mature rats with fetal alcohol syndrome].
Biulleten' eksperimental'noĭ biologii i meditsiny 1997;123(3):302-4.
1996: AN Inozemtsev; Tatiana A Voronina; LL Pragina; I A Krutikova; NA Tushmalova
[Differences in the effects of piracetam and fenazepam in emotional stress caused by the spatial reversal of a habit].
Eksperimental'naia i klinicheskaia farmakologiia 1996;59(6):3-5.
1996: Tatyana A Gudasheva; S S Boĭko; V Kh Akparov; RU Ostrovskaia; G G Rozantsev; Tatiana A Voronina; VP Zherdev; SB Seredenin
[Identification in the rat brain of cyclo-prolylglycine, a novel endogenous peptide with nootropic activity].
Doklady Akademii nauk / [Rossiĭskaia akademii nauk] 1996;350(6):834-6.
1996: L N Nerobkova; N V Markina; Tatiana A Voronina; V A Kraĭneva; Taissia L Garibova; G M Molodavkin; L M Sharkova
[Sleep disorders and impaired learning ability in rats with parkinsonian syndrome induced by MPTP].
Biulleten' eksperimental'noĭ biologii i meditsiny 1996;122(9):288-91.
1996: Tatyana A Gudasheva; S S Boyko; V Kh Akparov; Rita U Ostrovskaya; S P Skoldinov; G G Rozantsev; Tatiana A Voronina; VP Zherdev; SB Seredenin
Identification of a novel endogenous memory facilitating cyclic dipeptide cyclo-prolylglycine in rat brain.
FEBS letters 1996;391(1-2):149-52.
1996: AN Inozemtsev; S B Bokieva; Tatiana A Voronina; NA Tushmalova
[Comparative effects of tranquilizing and nootropic agents on development and functional disturbance of escape reaction].
Biulleten' eksperimental'noĭ biologii i meditsiny 1996;122(8):152-5.
1996: S S Boĭko; VP Zherdev; Tatyana A Gudasheva; N I Vasilevich; RU Ostrovskaia; Tatiana A Voronina; G G Rozantsev
[The use of the HPLC method for the quantitative determination of a peptide analog of piracetam with nootropic activity and its main metabolites].
Eksperimental'naia i klinicheskaia farmakologiia 1996;59(2):38-40.
1996: AN Inozemtsev; S B Bakieva; Tatiana A Voronina; NA Tushmalova
[A reversible functional disorder of the escape reaction as a model for studying the effect of tranquilizers].
Eksperimental'naia i klinicheskaia farmakologiia 1996;59(2):3-5.
1996: Elena I Solntseva; IuV Bukanova; RU Ostrovskaia; Tatyana A Gudasheva; Tatiana A Voronina; V G Skrebitskiĭ
[Effect of the nootropic agents piracetam and GBS-111 on potential-dependent ion channels in the neuronal membrane].
Biulleten' eksperimental'noĭ biologii i meditsiny 1996;121(2):151-5.
1995: S S Boĭko; Tatiana A Voronina; VP Zherdev; N G Chobanov
[The transplacental transport and effect of morphine administered in the prenatal period on its level in adult rats].
Eksperimental'naia i klinicheskaia farmakologiia 1995;58(6):42-4.
1995: N G Chobanov; Tatiana A Voronina; S S Boĭko; VP Zherdev
[Change in plasma morphine level and pain sensitivity in prenatally morphinized rats].
Biulleten' eksperimental'noĭ biologii i meditsiny 1995;120(9):273-5.
1995: AN Inozemtsev; P L Pragina; F A Firova; SS Trofimov; Tatyana A Gudasheva; NA Tushmalova; RU Ostrovskaia; Tatiana A Voronina
[A comparative analysis of the effect of nootropic preparations with different chemical structures on the failure of the escape reaction in rats].
Eksperimental'naia i klinicheskaia farmakologiia 1995;58(3):15-6.
1994: E L Maksutova; AK Sariev; VP Zherdev; Tatiana A Voronina; E V Zheleznova
[The pharmacokinetic characteristics of fenazepam in epileptics].
Eksperimental'naia i klinicheskaia farmakologiia 1994;57(2):16-8.
1993: AN Inozemtsev; T L Garibova; I V Khromova; R Alvarez; Tatiana A Voronina; NA Tushmalova
[The effect of nooglutil and piracetam on different forms of operant learning].
Eksperimental'naia i klinicheskaia farmakologiia 1993;56(2):6-8.
1991: N N Zolotov; O A Kutenova; Tatiana A Voronina; V F Pozdnev; L D Smirnov; K M Diumaev
[The possible participation of brain peptidases in regulating the memory function during aging].
Doklady Akademii nauk SSSR 1991;317(1):234-7.
1991: Tatiana A Voronina; T L Garibova; S S Trofimov; Zh A Sopyev; VD Petkov; M B Lazarova
Comparative studies on the influence of ONK (N(5-hydroxynicotinoil) glutamic acid), piracetam and meclofenoxate on the learning- and memory-impairing effect of scopolamine, clonidine, and methergoline.
Acta physiologica et pharmacologica Bulgarica 1991;17(4):8-16.
1990: Tatiana A Voronina; T L Garibova; I V Khromova; E A Kuznetsova; L D Smirnov
[A new substance with nootropic activity--N-5(hydroxynicotinoyl)-L-glutamic acid].
Farmakologiia i toksikologiia 1990;53(4):13-6.
1990: LL Pragina; Tatiana A Voronina; AN Inozemtsev; F F Kokaeva; NA Tushmalova
[The effect of piracetam and nicergoline on conditioned-reflex memory under conditions of extreme exposure].
Farmakologiia i toksikologiia 1990;53(3):8-10.
1990: Tatiana A Voronina; T L Garibova; R Barch; A Rostock; I V Khromova; G N Artemenko; K Zigemund; V Hoffmann
[The psychotropic properties of bonnecor and ethacizine].
Farmakologiia i toksikologiia 1990;53(3):52-4.
1989: L N Nerobkova; Tatiana A Voronina; N V Markina; I Kh Rakhmankulova
[Electrographic correlates of the antiamnestic action of nootropic agents following deprivation of the paradoxical sleep phase].
Biulleten' eksperimental'noĭ biologii i meditsiny 1989;108(12):697-700.
1988: AK Sariev; S V Krapivin; Tatiana A Voronina; VP Zherdev
[Pharmacokinetic, behavioral and neurophysiological aspects of the action of 2-ethyl-6-methyl-3-hydroxypyridine in rats].
Biulleten' eksperimental'noĭ biologii i meditsiny 1988;106(8):165-7.
1988: Tatiana A Voronina; L N Nerobkova; Taissia L Garibova; M Dikova; R Nikolov; M Nikolova; N V Markina
Effect of nicergoline on learning and memory.
Methods and findings in experimental and clinical pharmacology 1988;10(7):431-5.
1988: VP Zherdev; AK Sariev; Tatiana A Voronina; N A Kliuev; L D Smirnov
[Metabolism of an antioxidant of the 3-hydroxypyridine class].
Farmakologiia i toksikologiia 1988;51(1):55-9.
1988: VP Zherdev; AK Sariev; Tatiana A Voronina
Pharmacokinetic profile and metabolism of 2-ethyl-6-methyl-3-hydroxypyridine in rats.
Annali dell'Istituto superiore di sanità 1988;24(3):467-73.
1987: Tatiana A Voronina; T L Garibova; Zh A Sopyev; Konstantin Voronin
[Psychotropic properties of nootropic substances with a cholinergic action component in single and long-term use].
Farmakologiia i toksikologiia 1987;50(5):12-5.
1987: R Nikolov; M Dikova; M Nikolova; Tatiana A Voronina; L Nerobkova; Taissia L Garibova
Cerebroprotective effect of nicergoline and interference with the anti-hypoxic effect of prostacyclin.
Methods and findings in experimental and clinical pharmacology 1987;9(8):479-84.
1987: Tatiana A Voronina; T L Garibova; I V Khromova; U M Tilekeeva
[Dissociation of the anti-amnesic and antihypoxic effects of nootropic and antihypoxic preparations].
Farmakologiia i toksikologiia 1987;50(3):21-4.
1987: VP Zherdev; L P Larionov; Tatiana A Voronina; J Janků; A A Dvorianinov
[Circadian changes in the pharmacokinetics and effects of fenazepam in rats].
Farmakologiia i toksikologiia 1987;50(3):75-9.
1987: U M Tilekeeva; Tatiana A Voronina; V I Kuz'min; D A Sopyev; A N Aliev
[Characteristics of the antihypoxic properties of 3-hydroxypyridine-class antioxidants].
Farmakologiia i toksikologiia 1987;50(1):74-7.
1987: Tatiana A Voronina; Zh A Sopyev; T L Garibova; L D Smirnov
[Role of the GABA- and cholinergic systems in the formation of a dissociated state to an antioxidant of the 3-hydroxypyridine class].
Biulleten' eksperimental'noĭ biologii i meditsiny 1987;103(1):66-8.
1986: Tatiana A Voronina; L D Smirnov; A I Aliev; V I Kuz'min; U M Tilekeeva
[Relationship between the chemical structure and anticonvulsant activity of 3-hydroxypyridine derivatives].
Farmakologiia i toksikologiia 1986;49(6):27-31.
1986: Tatiana A Voronina; T L Garibova; L D Smirnov; O A Kutepova; K M Diumaev
[Geropsychotropic properties of an antioxidant of the 3-hydroxypyridine class in an experiment].
Biulleten' eksperimental'noĭ biologii i meditsiny 1986;102(9):307-10.
1986: N V Markina; L N Nerobkova; Tatiana A Voronina
[Effect of drugs of the nootropic class on rat behavior after deprivation of the paradoxical stage of sleep].
Zhurnal vyssheĭ nervnoĭ deiatelnosti imeni I P Pavlova 1986;36(5):963-7.
1986: Tatiana A Voronina; L D Smirnov; U M Tilekeeva; K M Diumaev
[The role of GABA-benzodiazepine receptor complex in affecting the anxiolytic effect of 3-hydroxypyridines--new non-benzodiazepine tranquilizers].
Biulleten' eksperimental'noĭ biologii i meditsiny 1986;101(5):571-3.
1986: VP Zherdev; AK Sariev; A A Dvorianinov; Tatiana A Voronina; L D Smirnov
[Pharmacokinetics of a water-soluble antioxidant from the class of 3-hydroxypyridines].
Biulleten' eksperimental'noĭ biologii i meditsiny 1986;101(3):325-7.
1985: I Kh Rakhmankulova; T L Garibova; Konstantin Voronin; U M Tilekeeva; Tatiana A Voronina
[Effects of piracetam during prolonged use in an experiment].
Farmakologiia i toksikologiia 1985;48(4):42-6.
1985: L D Smirnov; Tatiana A Voronina; K M Diumaev
[Effect of a membrane modulator from the 3-hydroxypyridine class on the pharmacological activity of a number of psychotropic preparations].
Biulleten' eksperimental'noĭ biologii i meditsiny 1985;99(5):519-22.
1985: A V Val'dman; Tatiana A Voronina; L D Smirnov; U M Tilekeeva; K M Diumaev
[Effect of 3-hydroxypyridine derivatives on the central nervous system].
Biulleten' eksperimental'noĭ biologii i meditsiny 1985;99(1):60-2.
1983: G M Rudenko; Iu V Chemesov; T L Garibova; Tatiana A Voronina
[Comparative characteristics of the psychotropic activity of "atypical" tranquilizers in an experiment].
Farmakologiia i toksikologiia 1983;46(3):26-9.
1980: Tatiana A Voronina; Taissia L Garibova; L N Nerobkova
[Characteristics of the anticonvulsant effects of fenazepam].
Farmakologiia i toksikologiia 1980;43(5):546-51.